ArticleCurrent oncology (Toronto, Ont.)2026
Implementation and Resource Optimization of an Oral Anticancer Medication Clinical Pharmacy Trainee Program: Operational and Financial Impact at a Tertiary Cancer Centre.
Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe emergence of oral anticancer medications (OAMs) has increased demand for specialized clinical pharmacy services (CPSs). Concurrently, Canadian cross-sectional data highlights undergraduate education gaps, with fewer than 14% of community pharmacists reporting adequate training on OAM therapies. We designed, implemented, and evaluated a pharmacist-led Oral Anticancer Medication Clinical Co-op Program (OAMCCP) to bridge this experiential education gap while cost-effectively expanding institutional capacity.
methodsLaunched in Fall 2022, the OAMCCP integrated one PharmD student per 16-week term into a multidisciplinary oncology specialty pharmacy. Trainees executed core ambulatory oncology clinical pharmacy key performance indicators (AOcpKPIs), including Best Possible Medication Histories (BPMHs), drug-drug interaction (DDI) screenings, and proactive adherence and toxicity follow-up. Student competency was verified by a licensed oncology pharmacist to maintain patient safety. Impact was quantified via self-reported task logging over 15 weeks, standardized 10-point patient satisfaction surveys, payroll expenditure comparisons, and student testimonials.
resultsTrainees completed 673 clinical tasks (~45 tasks/week), contributing 16.2 h of direct clinical support weekly-effectively adding +0.43 full-time equivalent (FTE) to service capacity. Mean patient satisfaction was 9.5/10 (
conclusionsThe OAMCCP resolves experiential training gaps while presenting a safe, scalable, and financially viable human resource framework that expands oncology pharmacy services.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.